By adding colon cancer cell-derived cfDNA or the TLR9 agonist CpG-ODN2395 to CRC cell lines, researchers found that the TLR9-MyD88 signaling boosted cell growth, migration, invasion, and IL8 secretion [206]. This evidence concerns the gene TLR9 and malignant colon neoplasm.